Aspira Women S Health Inc (AWHL) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Aspira Women s Health inc   (AWHL)


Aspira Women S Health Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Aspira Women S Health Inc 's ROA in the second quarter of 2026?
Aspira Women S Health Inc recorded a cumulative net loss of $-10 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -180.34%.

However, within the Healthcare sector 837 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4457, from total ROA ranking in the first quarter of 2026 at 5202.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -10.11 % -24.24 % -0.64 % 51.54 % 24.56 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -10 -10 -13 -11 -9
Return On Assets (TTM) -180.34 % -180.71 % -210.21 % -177.37 % -172.68 %
AWHL's Total Ranking # 4457 # 5202 # 4569 # 4639 # 4728
Total Assets (TTM) in million 4 5 5 7 5
Seq. Total Assets Change -12.83 % -6.74 % -24.35 % 46.17 % -26.53 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 14
Sector # 838
Overall # 4410

Return On Assets Statistics
High Average Low
-43.99 %
-161.37 %
-1087.15 %
(Dec 31 2012)   (Dec 31 2020)





Financial Statements
Aspira Women S Health Inc 's Assets $ 4 million AWHL's Balance sheet
Aspira Women S Health Inc 's Income $ -2 million Quarterly AWHL's Income Statement
AWHL's Income by Division See AWHL's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change -0.64 % -12.31 % -63.96 % -57.71 % 109.53 %
Total Assets in million 5 5 6 17 41
Y / Y Net Income Change - - - - -
Net Income in million -13 -13 -17 -30 -32
Annual Return On Assets -234.24 % -238.46 % -266.53 % -172.02 % -77.08 %




More Return On Assets Ratios
AWHL's' Return on Assets at Yahoo Finance
In Vitro & In Vivo Diagnostic Substances Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AWHL's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AWHL's Competitors
Subscribers only: Roa for Aspira Women S Health Inc 's Suppliers
Subscribers only: Return On Assets for AWHL's Customers

You may also want to know
AWHL's Roi AWHL's Inventory Turnover Ratio AWHL's Growth Rates AWHL's Dividend Comparisons
AWHL's Profitability Ratios AWHL's Asset Turnover Ratio AWHL's Dividend Growth
AWHL's Roe AWHL's Valuation Ratios AWHL's Financial Strength Ratios AWHL's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA


Date modified: 2026-09-18T14:07:36+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.